摘要
目的本文就同步放化疗治疗中晚期宫颈癌的临床效果进行研究。方法选取我院在2012年收治的110例中晚期宫颈癌患者,按照患者意愿分为实验组与参照组,每组55例。对实验组患者施以同步放化疗治疗,对参照组患者施以单纯放射治疗,对比不同疗法下两组患者的近远期疗效。结果实验组患者的肿瘤缓解率显著高于参照组,实验组患者的远处转移率、局部复发率对比参照组更低,5年生存率对比参照组更高,P<0.05。结论对中晚期宫颈癌患者实施同步放化疗进行治疗,患者的近、远期疗效均较理想,对预防远处转移及复发均有显著效果,具有较高的临床推广价值。
Objective To study clinical effect of concurrent chemoradiotherapy in treatment of advanced cervical cancer. Methods Choose 110 cases middle and advanced cervical cancer patients in our hospital in 2012, and divide them into experimental and reference group according to patient＇s wishes, 55 cases in each. Experimental group was treated with concurrent chemoradiotherapy, and reference group with radiotherapy only. Compare near and long term effect of two groups. Results Tumor remission rate of experimental group was significantly higher than reference group. Distant metastasis rate and local recurrence rate of experimental group was lower than reference group, and 5 year survival rate was higher than reference group, P〈0.05. Conclusion Concurrent chemoradiotherapy is effective for advanced cervical cancer patients, with ideal short and long term effects, and effective for preventing distant metastasis and recurrence, which is of high clinical promotion value.
作者
高洁
夏依拉.艾合买提
谢丽
古丽娜.库尔班
GAO Jie;Chaira Akomati;XIE Li;Guriana Kuerban(Inpatient Area No. 1, Gynecologic Oncology and Radiotherapy Department, Xinjiang Medical University Affiliated Cancer Hospital, Urumqi, Xinjiang, 830011)
出处
《智慧健康》
2018年第3期93-94,共2页
Smart Healthcare
关键词
同步放化疗
中晚期宫颈癌
复发
远处转移
Concurrent chemoradiotherapy
Middle and advanced cervical cancer
Recurrence
Distant metastasis
